STERIS Corporation - Helping to provide a healthier today and a safer tomorrow.
truFreeze Spray Cryotherapy

truFreeze® Spray Cryotherapy System

The truFreeze® Spray Cryotherapy ablation technology system is indicated for the treatment of esophageal and airway diseases, such as Barrett's esophagus and esophageal cancer, by delivering liquid nitrogen (LN2) at -196°C. LN2 is the coldest cryogen available and the only cryogen capable of ablating benign and malignant cells. Liquid nitrogen spray cryotherapy traps and flash-freezes water in cells causing cell death while preserving the extracellular matrix, promoting a rejuvenative healing response.

REQUEST A QUOTE OR INFORMATION

TruFreeze Spray Cryotherapy Console

truFreeze® Spray Cryotherapy Console

The truFreeze® Spray Cryotherapy console allows for delivery of liquid nitrogen (LN2) during both active and passive venting procedures.

 

Rapid AV Catheter

Active Venting Solutions - Rapid AV™ Catheter

The truFreeze® Spray Cryotherapy System is the only device indicated to ablate Barrett’s Esophagus with high grade dysplasia and/or low grade dysplasia, as well as to ablate malignancies such as esophageal cancer. The Rapid AV™ catheter was designed for use in procedures requiring active venting, such as gastroenterology cases. This specially designed catheter features decreased time to frost by 50%, minimizing overall ablation time.

Passive Venting Solutions - Air PV Catheter

Passive Venting Solutions - Aire PV™ Catheter

The Aire PV™ Catheter is designed for the delivery of spray cryotherapy for airway disease and pulmonary applications, supporting the passive venting method – gas dispersing from the area by natural diffusion.